Zefur

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Zefur

This section provides an overview of the identity, composition, and classification of the medicine Zefur (Cefuroxime).

Property Description
Active ingredient Cefuroxime (or Cefuroxime Axetil)
Form Tablets, Oral Suspension, Sterile Powder for Injection
Pharmacological class Second-Generation Cephalosporin Antibiotic
Common purpose Systemic elimination of susceptible bacteria
Origin Semi-synthetic

What Type of Antibiotic is Zefur (Cefuroxime)?

Zefur is a prescription-only medicine whose active ingredient, Cefuroxime, is classified as a second-generation cephalosporin antibiotic. This designation places it within the larger beta-lactam family of antimicrobials, distinguished by its semi-synthetic origin and bactericidal mechanism.

As a second-generation cephalosporin, Cefuroxime provides enhanced stability against certain bacterial defense mechanisms, specifically beta-lactamase enzymes, compared to older antibiotics in this class. Its general purpose is to act as a systemic antibacterial agent, utilizing its bactericidal property to directly kill susceptible bacteria throughout the body. Cefuroxime is frequently clinically recognized for its effectiveness against a range of pathogens in typical bacterial infections, such as those affecting the respiratory tract. The cephalosporin class functions through its selective binding to bacterial proteins essential for cell structure, leading to cell death.


Cefuroxime: Composition and Available Forms

The medication's primary component is Cefuroxime. However, for oral use, it is often supplied as the Cefuroxime Axetil prodrug, which is then converted into active Cefuroxime after absorption. The medicine is a single-agent product manufactured in multiple dosage forms to suit different routes of administration. These forms include tablets, an oral suspension (liquid) frequently used for pediatric patients, and a sterile powder for injection (for intravenous or intramuscular delivery). The availability of both oral and parenteral forms ensures effective delivery regardless of the patient's condition, highlighting the medicine's versatility in different clinical settings.

What side effects are possible with Zefur?

Possible side effects and safety information

Official regulatory documents classify the possible adverse reactions of Zefur (Cefuroxime) based on their frequency and the body system affected. These classifications establish the medicine's formal safety profile, focusing strictly on events documented in clinical use and post-marketing surveillance.


Frequency and System-Organ Class

The most frequently documented side effects are classified as Common (ge 1/100 to < 1/10). These often involve Gastrointestinal disorders (e.g., diarrhea, nausea, abdominal pain) and Infections and infestations (e.g., candidiasis or yeast overgrowth). Uncommon reactions may include specific changes in the Blood and lymphatic system disorders, such as transient leukopenia or thrombocytopenia, and skin manifestations like rash.


Serious Adverse Reactions and Restrictions

Regulatory labeling highlights specific Serious Adverse Reactions. These include severe, though rare, hypersensitivity reactions such as anaphylaxis, which is a particular safety concern for individuals with a history of allergy to other beta-lactam antibacterial drugs (e.g., penicillins). Other serious events include Pseudomembranous colitis, which is linked to Clostridioides difficile overgrowth and can occur even after treatment ends, and severe cutaneous reactions (SCARs).


Population-Specific Safety Notes

The medicine is primarily eliminated by the kidneys, and official documents note that its clearance may be reduced in older adults with diminished renal function. Furthermore, the oral suspension contains phenylalanine, which is a formal safety consideration for patients diagnosed with Phenylketonuria (PKU).

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory information describes specific manifestations and mandatory actions related to a Zefur (Cefuroxime) overdose, strictly defining when emergency medical care is required.

Overdosage may result in central nervous system effects, including seizures and signs of cerebral irritation. Severe, life-threatening neurological outcomes such as encephalopathy and coma are also officially documented in regulatory reports. Patients with renal impairment are noted to be at an elevated risk of these symptoms if the dose is not reduced to account for decreased drug clearance.

Required Emergency Actions

Regulators mandate that immediate medical attention must be sought for individuals who have collapsed, are having difficulty breathing, or are experiencing seizures after exposure. Patients should contact emergency services or a poison control center immediately for instructions.

Overdose Management

Management for an overdose is described as symptomatic and supportive. The official labeling confirms that no specific antidote exists for Cefuroxime. Procedural measures such as hemodialysis and peritoneal dialysis are noted as means by which high concentrations of the drug in the system can be effectively reduced.

Therapeutic Uses of Zefur

What Zefur Treats: Main Uses and Benefits

Zefur is commonly used to address symptoms related to bacterial infections across several key therapeutic domains. It is applied in clinical settings that involve acute or unstable symptom patterns.

These uses include helping address symptoms of pneumonia, acute bronchitis exacerbations, sinusitis, otitis media (ear infection), tonsillitis, and pharyngitis. It is also relevant in conditions presenting with systemic or localized discomfort, such as uncomplicated skin infections (like cellulitis), UTIs, gonorrhea, and the rash associated with early Lyme disease. The medication supports the patient during difficult episodes by easing distress and contributes to easing the overall symptom load. It may assist in supporting functional stability when symptoms create noticeable physiological strain.

“The medication is relevant to provide supportive relief during symptomatic phases and helps patients cope more steadily with difficult episodes.”

Quick Fact: Relief for Localized Pain Zefur is commonly used to help with acute pain and swelling associated with ear, throat, and uncomplicated skin infections.

Regulatory References

  1. Official FDA Product Labeling via NIH DailyMed

Eligibility and Restrictions for Use

Who Can and Cannot Use Zefur?

Eligibility to use Zefur (Cefuroxime) is governed by official regulatory standards, with clear rules for both approved use and contraindications.

Classification Eligibility Rule Reference
Absolute Contraindication Patients with known hypersensitivity to Cefuroxime, any cephalosporin antibiotic, or a history of a severe allergic reaction (e.g., anaphylaxis) to any beta-lactam antibacterial agent (e.g., penicillin) must not use Zefur. (FDA, EMA)
Established Age Groups Use is approved for adults and pediatric patients ge 3 months of age. Injectable forms are indicated for use in children, including neonates (from birth), in certain regions. (FDA, EMA)
Conditional/Restricted Use Individuals with markedly impaired renal function require administration with caution and a reduced dosage to compensate for slower drug excretion, as stated in the label. The oral suspension form may contain phenylalanine and requires caution for patients with Phenylketonuria (PKU). (FDA, SmPC)
Use Not Established The safety and effectiveness of the oral suspension formulation are not established in infants younger than 3 months of age. (FDA, SmPC)
Pregnancy/Lactation Use during pregnancy is advised only if clearly needed. Caution is advised when administering Zefur to a nursing mother, as the drug is known to be excreted in human milk in low concentrations. (FDA)

These official criteria define the absolute limits and required precautions for Cefuroxime use, ensuring it is prescribed only when patient status aligns with documented eligibility and risk profiles.

What should I know about interactions with other medicines?

Interactions with Other Medicines and Products

The official interaction profile for Zefur (Cefuroxime Axetil) is structured around substances that modify its systemic exposure or affect other therapies, as documented in government regulatory sources.

Pharmacokinetic and Drug-Drug Interactions

Interacting Substance/Class Official Documented Interaction Regulatory Restriction/Note
Probenecid Reduces renal tubular secretion, significantly increasing Cefuroxime serum concentration and AUC (systemic exposure). Co-administration is not recommended.
Gastric Acidity Reducers (e.g., Antacids, H2-antagonists) Result in a lower bioavailability (reduced absorption) of Cefuroxime Axetil. Short-acting antacids should be given 1 hour before or 2 hours after Cefuroxime Axetil.
Oral Contraceptives May affect gut flora, potentially leading to reduced efficacy of combined oral contraceptives. Use of an alternative contraceptive method is advised.
Oral Anticoagulants May potentiate the anticoagulant effect, leading to a possible increase in the INR. Coagulation parameters should be monitored.
Potent Diuretics Should be given with caution due to a suspicion of adversely affecting renal function. Caution advised, particularly in patients with impaired renal function.

Laboratory Test Interference

Cefuroxime can cause a false-positive reaction for glucose in urine using copper reduction tests and a false-negative result in the ferricyanide test for blood/plasma glucose. Additionally, a positive direct Coombs Test may occur.

Mechanism of Action

Disrupting the Bacterial Cell Wall

Zefur's mechanism of action focuses on its primary targets: Penicillin-Binding Proteins (PBPs), which are essential enzymes in the terminal stage of bacterial cell wall construction. Zefur acts as an irreversible inhibitor by covalently binding to these proteins, thereby preventing the crucial peptidoglycan cross-linking required for the cell wall's structural integrity. This targeted molecular interaction immediately arrests the proper assembly of the bacterial outer layer.

Mechanistic Cascade Leading to Cell Death

The inhibition of PBPs triggers a subsequent mechanistic cascade. The resulting structural weaknesses compromise the cell wall, causing it to fail against internal osmotic pressure. This cascade leads directly to cellular lysis—the physical rupture and death of the bacterial organism. This focused destruction prevents bacterial cell replication and halts the source of biological disruption caused by the target organisms, establishing the drug's core pharmacodynamic consequence.

Dosage and Administration Information

Zefur (cefuroxime) is an antibiotic prescribed to treat a variety of bacterial infections. The precise dosage, duration of therapy, and administration route are determined by the treating healthcare provider based on the type and severity of the infection, and patient factors such as age and weight.

Oral Administration (Tablets and Suspension)

  • Tablets: The film-coated tablets should be swallowed whole with or without food. They should not be crushed, split, or chewed, as the active ingredient has a strong, persistent bitter taste and crushing may affect absorption.
  • Suspension (Liquid): The oral liquid form must be taken with food for improved absorption. Shake the suspension well before each use and accurately measure the dose using a specialized measuring device, not a household spoon.

Key Patient Instructions

Instruction Detail
Dosing Schedule Take the medication at the same time every day to maintain a consistent concentration of the drug in the body.
Completion of Course Complete the entire course of therapy as prescribed, even if symptoms begin to improve before the medication is finished. Stopping prematurely can result in the infection not being fully treated and may contribute to the development of antibiotic-resistant bacteria.
Missed Dose If a dose is missed, take it as soon as it is remembered. However, if it is almost time for the next scheduled dose, skip the missed one and continue with the regular schedule. Do not take a double dose to make up for a missed one.
Storage Store Zefur tablets at room temperature away from excessive heat and moisture. The oral liquid suspension should typically be stored in the refrigerator, and any unused portion should be discarded after 10 days, or as directed on the prescription label.

Inform your healthcare provider and pharmacist of all concurrent medications, vitamins, and supplements, as certain products (e.g., antacids containing magnesium or aluminum, and some oral contraceptives) may interact with Zefur.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Zefur

This section summarizes the structure of the clinical research that has evaluated Zefur (Cefuroxime), focusing on the types of studies conducted, the specific outcomes measured, and the recognized limitations within the official evidence record.


Evidence for Respiratory Tract Conditions: Bronchitis, Pneumonia, and Sinusitis

Research exploring Zefur's use for respiratory conditions is heavily based on Randomized Controlled Trials (RCTs). These studies were designed to compare Zefur against alternative treatments used for similar conditions in adults. For acute exacerbations of chronic bronchitis, studies monitored symptom change and microbiological outcomes during the study period. For community-acquired pneumonia, research explored outcomes related to systemic or functional imbalance, such as hospital stay duration and time to clinical stability. Official documents sometimes note that evidence certainty for some trial comparisons is low due to differences in study designs.


Evidence for Ear, Throat, Skin, and Systemic Conditions

Zefur has been evaluated in short-term RCTs for conditions like acute bacterial otitis media in pediatric outpatients, where researchers monitored outcomes related to measured changes in ear-related signs and symptoms. Similarly, studies explored pharyngitis and uncomplicated skin infections, monitoring changes in symptoms and bacteriological status.

For early Lyme disease, research is an instance where studies monitored patients over an extended period, sometimes up to one year, to assess for the absence of signs of late complications. For most common infections, long-term outcomes are not fully established, as follow-up durations were often limited to shortly after the end of treatment.


Key Limitations and Areas of Uncertainty in Research

The evidence landscape contains several recognized limitations. For many common indications, studies were designed to explore whether Zefur was associated with measured outcomes that were comparable to established alternative antibiotics. Direct evidence exploring a superior outcome is often noted as lacking in the research record. Furthermore, data for infants younger than 3 months of age are sparse, and for certain conditions like pharyngitis, the available research does not determine or provide sufficient long-term data regarding the prevention of secondary complications. Research provides context but not individual predictions regarding an individual patient's response.

Key Studies & References

  1. Cefuroxime Axetil Tablet: Official Product Labeling and Regulatory Findings
  2. Urinary tract infection (lower): antimicrobial prescribing (NICE Guideline summarizing evidence for UTIs)

Frequently Asked Questions (FAQ)

Common questions about Zefur (FAQ)


Q: Does Zefur work for common colds or the flu?

A: Zefur is an antibacterial drug, meaning it is designed to treat or prevent infections caused by susceptible bacteria. According to the official product information, it is not intended for the treatment of viral illnesses, such as the common cold or the flu. Antibiotics are only useful against bacteria.


Q: Is a metallic or unpleasant taste in the mouth normal when taking Zefur?

A: An unpleasant or changed taste in the mouth is listed in official regulatory documents as a less common side effect associated with Zefur use. If the film coating on the tablet is compromised, the active ingredient is described as having a strong, persistent bitter taste. The unpleasant taste is typically temporary and may subside after the medicine is finished.


Q: Can people with a known penicillin allergy safely take Zefur?

A: Zefur is contraindicated for use in patients with a known severe allergy (hypersensitivity) to beta-lactam antibacterial drugs, which includes penicillins. Patients are generally advised to inform their healthcare provider of any history of allergic reactions, particularly severe ones, to antibiotics like penicillin, as Zefur belongs to a related class of medicines (cephalosporins).


Q: Are there any specific foods or drinks that should be avoided with Zefur?

A: Official regulatory information does not typically list specific foods to avoid while taking Zefur. For absorption, the oral suspension (liquid) formulation must be taken with food. The tablet formulation may be taken with or without food. All dietary concerns should be discussed with a healthcare provider.


Q: Can Zefur cause changes in appetite or unusual weight loss?

A: Loss of appetite is listed as a rare side effect associated with Zefur use. While this may happen, unusual weight changes are not explicitly listed in the formal safety profile as a frequent side effect.


Q: Is Zefur known to cause confusion or trouble concentrating?

A: Specific issues like confusion or trouble concentrating are not commonly listed in the safety profile. However, dizziness is a common side effect and sleepiness or unusual drowsiness (somnolence) is a rare side effect. Official reports also note rare severe nervous system effects like seizures.


Q: Can Zefur be taken at the same time as common over-the-counter pain relievers?

A: Official interaction summaries for Zefur do not list a known major drug interaction with non-prescription pain relievers such as ibuprofen or acetaminophen. It is standard practice to inform a healthcare provider of all concurrent medications, vitamins, and supplements.


Q: Is Zefur considered a sulfa drug?

A: No, Zefur is not classified as a sulfonamide (sulfa) drug. Its active ingredient, Cefuroxime, is a second-generation cephalosporin antibiotic, which belongs to the larger beta-lactam family of antimicrobials.


Q: How quickly should I expect Zefur to start working for an infection?

A: The active component of Zefur reaches systemic levels relatively quickly after administration. Clinical guidelines typically advise monitoring for signs of improvement and clinical stability—such as reduced fever or pain—within 48 to 72 hours of starting treatment.


Q: Is it okay to consume alcohol in moderation while taking Zefur?

A: Formal regulatory documents for Zefur do not list a known interaction with alcohol that would require avoidance during therapy. Patients typically follow their healthcare provider's general advice regarding alcohol consumption while recovering from an infection.


Q: How long is the typical course of Zefur treatment for most infections?

A: Official guidelines state a standard treatment duration of 5 to 10 days for most common bacterial infections. The specific length of therapy, however, is determined by the healthcare provider based on the type, location, and severity of the infection being treated.


Q: Is dizziness or feeling tired a known side effect of Zefur?

A: Dizziness and headache are listed as common side effects associated with Zefur. Unusual tiredness or weakness is also documented as a less common side effect in the official safety profile.


Q: Is a red rash that appears while taking Zefur a definite sign of an allergic reaction?

A: A mild skin rash is listed as an uncommon side effect and does not always indicate a severe allergy. However, any severe, widespread, or blistering rash, or a rash accompanied by hives or swelling, is considered a serious event and generally warrants prompt notification of a healthcare provider.


Q: Is Zefur used for ear infections in children?

A: Yes, Zefur is indicated for the treatment of conditions such as acute bacterial otitis media (ear infection) in pediatric patients 3 months of age and older.


Q: What precautions should be taken if Zefur is prescribed to someone with a history of colitis?

A: Official warnings state that Zefur, like other broad-spectrum antibiotics, should be administered with caution to individuals with a history of gastrointestinal disease, particularly colitis. This is due to the potential risk of Clostridioides difficile overgrowth.


Q: Does Zefur have any effect on my ability to drive or operate machinery?

A: Because Zefur can cause side effects like dizziness and, rarely, sleepiness, patients are officially advised to be cautious when driving or operating machinery until they know how the medicine affects them personally.


Q: Can Zefur affect the levels of liver enzymes in the blood?

A: Official documents note that a transient rise in certain liver enzymes (such as SGOT and SGPT) has been reported in a small percentage of patients using Zefur. These changes are usually temporary.


Q: Are there studies on the long-term safety of Zefur?

A: While initial clinical trials often focus on short-term outcomes, the medicine's safety profile is continuously monitored through official post-marketing surveillance programs. These programs collect long-term reports of adverse events experienced by patients after the medicine has been approved.

How should Zefur be stored and disposed of?

Storage and Disposal Requirements

Official regulatory documents define specific conditions for storing Zefur (Cefuroxime) to maintain its stability. The unreconstituted powder for injection must be stored at temperatures not exceeding 30°C and must not be frozen. Oral tablets and injection vials should be kept in their original packaging to protect from light and moisture.

Reconstituted solutions, such as the injection, have a short in-use stability period, often requiring use within 24 hours when refrigerated. The medicine must always be stored out of the sight and reach of children.

To dispose of unused or expired Zefur, follow local requirements for drug take-back. The product must not be disposed of via wastewater or regular household waste.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Zefur found in:

A-Z Index: